97 results
Page 2 of 5
8-K
EX-99.1
lmjdtgd7i 1xllh3sh9t
11 Aug 22
Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel
4:07pm
8-K
EX-10.1
qwa 9mg9ys
15 Jun 22
Entry into a Material Definitive Agreement
6:07am
8-K
EX-99.1
z3bgdic home8
12 May 22
Sientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022
4:09pm
8-K
EX-99.1
iaxk3
24 Mar 22
Sientra Receives Regulatory Approval to Market Breast Implants in Canada
8:56pm
8-K
EX-10.1
m4pzj1x72deokeggx
5 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
EX-99.1
h44d5ai4i 65o
11 Mar 21
Sientra Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
424B5
wnl3zvj1oc9c mv3v2
9 Feb 21
Prospectus supplement for primary offering
4:43pm
8-K
EX-1.1
dciamof guroxf3fb
9 Feb 21
Sientra Commences Public Offering of Common Stock
4:05pm
424B5
914g836k 4dsm
8 Feb 21
Prospectus supplement for primary offering
4:02pm
8-K
EX-10.1
7du aezn3jv27u
8 Feb 21
Entry into a Material Definitive Agreement
6:09am
8-K
EX-99.1
zpje4tcgx4xe4r6
25 Aug 20
Sientra Receives Regulatory Approval to Market OPUSĀ® Breast
4:05pm